DK1392335T3 - Farmaceutisk og/eller kosmetisk sammensætning til behandling af lokal adipositas og cellulite - Google Patents

Farmaceutisk og/eller kosmetisk sammensætning til behandling af lokal adipositas og cellulite

Info

Publication number
DK1392335T3
DK1392335T3 DK02732718T DK02732718T DK1392335T3 DK 1392335 T3 DK1392335 T3 DK 1392335T3 DK 02732718 T DK02732718 T DK 02732718T DK 02732718 T DK02732718 T DK 02732718T DK 1392335 T3 DK1392335 T3 DK 1392335T3
Authority
DK
Denmark
Prior art keywords
pharmaceutical
cellulite
treatment
phospholipids
complex
Prior art date
Application number
DK02732718T
Other languages
Danish (da)
English (en)
Inventor
Pierro Francesco Di
Original Assignee
Indena Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Indena Spa filed Critical Indena Spa
Application granted granted Critical
Publication of DK1392335T3 publication Critical patent/DK1392335T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/06—Preparations for care of the skin for countering cellulitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/16—Ginkgophyta, e.g. Ginkgoaceae (Ginkgo family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37—Esters of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
    • A61K8/498—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom having 6-membered rings or their condensed derivatives, e.g. coumarin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/55—Phosphorus compounds
    • A61K8/553—Phospholipids, e.g. lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A61K8/602—Glycosides, e.g. rutin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/63—Steroids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9771—Ginkgophyta, e.g. Ginkgoaceae [Ginkgo family]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9789—Magnoliopsida [dicotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Birds (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medical Informatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Molecular Biology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Biophysics (AREA)
  • Child & Adolescent Psychology (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
DK02732718T 2001-06-05 2002-05-16 Farmaceutisk og/eller kosmetisk sammensætning til behandling af lokal adipositas og cellulite DK1392335T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT2001MI001182A ITMI20011182A1 (it) 2001-06-05 2001-06-05 Composizioni farmaceutiche e/o cosmetiche per il trattamento di adiposita' localizzate e della cellulite
PCT/EP2002/005390 WO2002098436A1 (en) 2001-06-05 2002-05-16 Pharmaceutical and/or cosmetic compositions for the treatment of localised adiposities and cellulite

Publications (1)

Publication Number Publication Date
DK1392335T3 true DK1392335T3 (da) 2007-09-17

Family

ID=11447807

Family Applications (1)

Application Number Title Priority Date Filing Date
DK02732718T DK1392335T3 (da) 2001-06-05 2002-05-16 Farmaceutisk og/eller kosmetisk sammensætning til behandling af lokal adipositas og cellulite

Country Status (23)

Country Link
US (1) US7476392B2 (de)
EP (1) EP1392335B1 (de)
JP (1) JP4762492B2 (de)
KR (1) KR100869868B1 (de)
CN (1) CN100340247C (de)
AT (1) ATE360427T1 (de)
AU (1) AU2002304632B2 (de)
CA (1) CA2449485C (de)
CY (1) CY1107672T1 (de)
CZ (1) CZ300576B6 (de)
DE (1) DE60219782T2 (de)
DK (1) DK1392335T3 (de)
ES (1) ES2284870T3 (de)
HK (1) HK1063295A1 (de)
HU (1) HU230348B1 (de)
IT (1) ITMI20011182A1 (de)
NO (1) NO331789B1 (de)
PL (1) PL204550B1 (de)
PT (1) PT1392335E (de)
RU (1) RU2291683C2 (de)
SI (1) SI1392335T1 (de)
SK (1) SK287612B6 (de)
WO (1) WO2002098436A1 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20021280A1 (it) * 2002-06-11 2003-12-11 Carlo Ghisalberti Metodo di trattamento anticellulite
FR2841470B1 (fr) * 2002-06-27 2006-01-13 Pharmascience Lab Utilisation d'isoflavones pour la preparation de compositions topiques utiles pour favoriser l'amincissement et methode de traitement cosmetique associee
ITMI20031428A1 (it) * 2003-07-11 2005-01-12 Indena Spa Combinazioni di agenti vasoattivi e loro uso per il trattamento di disfunzioni sessuali
ITMI20031427A1 (it) * 2003-07-11 2005-01-12 Indena Spa Combinazioni di agenti vasoattivi, loro uso in campo farmaceutico e cosmetico e formulazioni che li contengono
US20050089555A1 (en) * 2003-10-24 2005-04-28 Aventis Pharma Deutschland Gmbh Medicinal targeted local lipolysis
DE10349979B4 (de) * 2003-10-24 2006-05-18 Sanofi-Aventis Deutschland Gmbh Medikamentöse gezielte lokale Lipolyse
US20050143347A1 (en) * 2003-12-22 2005-06-30 Aventis Pharma Deutschland Gmbh Medicinal lipolysis of accumulations of fat
KR20070086101A (ko) * 2004-12-14 2007-08-27 메나리니 리케르체 에스.피.아. 셀룰라이트 치료용 약제학적 조성물
EP1849481A4 (de) * 2005-01-07 2012-11-28 Rohto Pharma Zusammensetzung zur topischen anwendung
DE102005061071A1 (de) * 2005-12-21 2007-06-28 Kneipp-Werke Kneipp-Mittel-Zentrale Gmbh & Co. Kg Wirkstoffkombination aus Santalbinsäure oder Derivate davon und Traubenkernöl zur topischen oder dermatologischen Verwendung
DE102007007610A1 (de) * 2007-02-13 2008-08-14 Beiersdorf Ag Verfahren zur Steigerung der Hautelastizität und/oder eine Stärkung der Spannkraft der Haut
ITTO20070391A1 (it) * 2007-06-05 2008-12-06 Medestea Res & Production S P Composizione di integratore alimentare,farmaco o dispositivo medicale e suo impiego per sopprimere l'appetito, migliorare tono ed umore, con attivita antidepressiva naturale e con effetto antiastenico
EP2419437A1 (de) * 2009-04-17 2012-02-22 Lipotec, S.A. Bei der behandlung und/oder pflege der haut und/oder der haare verwendete peptide und ihre verwendung in kosmetischen oder pharmazeutischen zusammensetzungen
KR101678254B1 (ko) * 2009-08-12 2016-11-21 호르파그 리서치 아이피 (피와이씨) 리미티드 동맥경화증과 같은 심혈관 장애의 치료용 피크노제놀 또는 포도씨와 같은 프로안토시아니딘 및 병풀의 조합
DE102009028996A1 (de) * 2009-08-28 2011-03-03 Rovi Cosmetics International Gmbh Kosmetische Formulierung zur Reduktion der äußeren Erscheinungsbilder von Cellulite oder Orangenhaut
FR2962907B1 (fr) * 2010-07-21 2015-05-08 Ephyla Sas Extrait de vegetal pour la fabrication de composition amincissante et procede de controle pour mincir mettant en oeuvre une telle composition
BE1022293B1 (nl) 2012-11-21 2016-03-14 Wendy Angrave Methode en composities om toxines te verwijderen uit het lichaam
EP2968107B1 (de) 2013-03-15 2019-05-08 Mary Kay, Inc. Kosmetikzusammensetzungen und verwendungen davon
CN103432045B (zh) * 2013-09-06 2015-06-24 雅露拜尔生物科技（杭州）有限公司 健美瘦身组合物及健美瘦身霜
US20240148686A1 (en) * 2021-02-24 2024-05-09 China Pharmaceutical University Pharmaceutical composition of forskolin-isoforskolin and pentacyclic triterpenoid compound, and application thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1203515B (it) * 1987-02-26 1989-02-15 Indena Spa Complessi di saponine con fosfolipidi e composizioni farmaceutiche e cosmetiche che li contengono
IT1223290B (it) * 1987-07-27 1990-09-19 Indena Spa Acidi poliinsaturi ad azione vasocinetica e relative formulazioni farmaceutiche e cosmetiche
FR2669537B1 (fr) * 1990-11-28 1993-02-19 Oreal Composition amincissante a base d'alpha-2-bloqueurs.
FR2684300B1 (fr) * 1991-11-29 1994-03-11 Lvmh Recherche Composition cosmetique ou pharmaceutique, notamment dermatologique, destinee en particulier a favoriser la pigmentation de la peau ou des cheveux, contenant un extrait de ballote, et son procede de fabrication.
JPH10182473A (ja) * 1996-12-25 1998-07-07 Lion Corp 皮下脂肪代謝促進剤及びそれを含む外用組成物
ATE292469T1 (de) 1999-09-10 2005-04-15 Ceteris Holding B V Amsterdam Ein antioxyrierungsmittel auf basis von pflanzenextrakten zur behandlung von kreislaufs- und fettsuchtproblemen

Also Published As

Publication number Publication date
CN1512889A (zh) 2004-07-14
PL204550B1 (pl) 2010-01-29
US7476392B2 (en) 2009-01-13
CA2449485A1 (en) 2002-12-12
HK1063295A1 (en) 2004-12-24
CA2449485C (en) 2010-09-28
KR100869868B1 (ko) 2008-11-24
HUP0400119A2 (hu) 2005-09-28
AU2002304632B2 (en) 2006-07-20
DE60219782D1 (de) 2007-06-06
WO2002098436A1 (en) 2002-12-12
RU2291683C2 (ru) 2007-01-20
JP2004532273A (ja) 2004-10-21
KR20040030637A (ko) 2004-04-09
NO331789B1 (no) 2012-04-02
ITMI20011182A0 (it) 2001-06-05
CN100340247C (zh) 2007-10-03
JP4762492B2 (ja) 2011-08-31
HU230348B1 (hu) 2016-02-29
CY1107672T1 (el) 2013-04-18
NO20035389D0 (no) 2003-12-04
CZ20033293A3 (en) 2004-04-14
SK14852003A3 (sk) 2004-05-04
EP1392335A1 (de) 2004-03-03
DE60219782T2 (de) 2008-01-24
RU2003135427A (ru) 2005-03-20
PT1392335E (pt) 2007-07-17
ES2284870T3 (es) 2007-11-16
HUP0400119A3 (en) 2007-10-29
SI1392335T1 (sl) 2007-08-31
SK287612B6 (sk) 2011-04-05
PL366914A1 (en) 2005-02-07
EP1392335B1 (de) 2007-04-25
ATE360427T1 (de) 2007-05-15
CZ300576B6 (cs) 2009-06-17
ITMI20011182A1 (it) 2002-12-05
US20040151786A1 (en) 2004-08-05

Similar Documents

Publication Publication Date Title
DK1392335T3 (da) Farmaceutisk og/eller kosmetisk sammensætning til behandling af lokal adipositas og cellulite
Pal et al. Activation of caspases and poly (ADP-ribose) polymerase cleavage to induce apoptosis in leukemia HL-60 cells by Inula racemosa
HK1069102A1 (en) Pharmeceutical and cosmetic compositions against skin aging
HUP0302881A2 (hu) Legalább egy D-vitamint vagy D-vitamin analóg vegyületet és legalább egy kortikoszteroidot tartalmazó külsőleges gyógyszerkészítmények
DE60206137D1 (de) Kräuterpflanzen enthaltende artzneimittel
DE60024290D1 (de) Hautpflegeproduct, welches gegen freie radikale wirkt
AR003496A1 (es) Procedimiento de tratamiento cosmetico no terapeutico de desordenes asociados con un exceso de sintesis y/o liberacion del cgrp y/o de sustancia p utilizacion de al menos un extracto de celulas de la menos un vegetal de la familia de las iridaceas y composicion cosmetica o farmaceutica que comprende dicho extracto
NO20060152L (no) Kombinasjoner av vasoaktive agenser, deres anvendelse innen farmasi og kosmetikk, og formuleringer inneholdende dem
Panda et al. Chemometric profile, antioxidant and tyrosinase inhibitory activity of Camel’s foot creeper leaves (Bauhinia vahlii)
BRPI0518554A2 (pt) uso de um inibidor de pde3
PT1035858E (pt) Utilizacao de extracto de ginkgo biloba para preparar um medicamento
HK1093901A1 (en) Oral compositions for the treatment of cellulite
Ignjatović et al. Evaluation of angiogenic and neuroprotective potential of different extracts from three Veronica species
CL2004000499A1 (es) Uso de una composicion que comprende extracto de panax ginseng (ginseng chino) y paullinia cupana (guarana) para la preparacion de un medicamento o suplemento dietetico util para mejorar las habilidades cognitivas; la composicion farmaceutica y suple
TH100024A (th) ไนโอโซนบรรจุสารสกัดจากสมุนไพร